Simultaneous Lung and Kidney Transplant in a Young Patient with COVID-19
1Houston Methodist Academic Pulmonary Medicine, Houston Methodist Hospital, Houston, TX, 2Houston Methodist Pulmonary Transplant Center, Houston Methodist Hospital, Houston, TX, 3Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
Meeting: 2022 American Transplant Congress
Abstract number: 1483
Keywords: COVID-19, HLA antigens, Kidney transplantation, Lung transplantation
Topic: Clinical Science » Lung » 64 - Lung: All Topics
Session Information
Session Time: 7:00pm-8:00pm
Presentation Time: 7:00pm-8:00pm
Location: Hynes Halls C & D
*Purpose: Lung transplant is the last resort for COVID-19 refractory ARDS. Dual organ transplant is seen as a relative contraindication at many institutions. We describe a case of simultaneous Lung-Kidney transplant (SLK) in a patient with COVID-19 ARDS.
*Methods: A 24-year-old patient with no PMH presented to an outside hospital with a week of shortness of breath, cough, and fever. Despite treatment with Remdesivir and dexamethasone, the patient developed hypoxemic respiratory failure with acute renal injury requiring ICU care and intubation, V-V ECMO, and dialysis. Additionally, Intravenous and inhaled Aviptadil were given under emergency use authorization. While oxygenation improved, the patient could not be weaned off ECMO. With a LAS score of 90.29, the patient underwent an SLK transplant on HD 53, requiring standard induction and maintenance immunosuppression therapy. The patient was treated post-operatively for PGD as well as for subclinical AMR. After successful inpatient rehabilitation, the patient was discharged home after four months and had a one-month follow-up on room air and normal creatinine clearance.
*Results: Patients with pre-existing renal dysfunction who have undergone lung transplants have a significantly higher one- and three-year mortality than patients with normal GFR. The patient’s survival after SLK was similar to isolated lung transplants at one and five years, according to an analysis of the UNOS/OPTN database. Still, dual organ transplant in the COVID-19 ARDS population is considered a contraindication at many centers, given these patients’ critical illness and frailty. However, the frailty in this population is reversible due to the rapid onset of disease in an otherwise previously healthy younger population with minimal comorbidities. Thus, multiorgan transplantation should be considered in such a patient population. Our patient received Aviptadil as part of an EIND to stabilize patients and improve oxygenation while waiting on the transplant list.
*Conclusions: We propose that SLK transplantation should be considered for carefully selected patients with COVID-19 ARDS.
To cite this abstract in AMA style:
Bitar M, Youssef JG, Yau S, Goodarzi A, Youssef G. Simultaneous Lung and Kidney Transplant in a Young Patient with COVID-19 [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/simultaneous-lung-and-kidney-transplant-in-a-young-patient-with-covid-19/. Accessed May 30, 2025.« Back to 2022 American Transplant Congress